Gojo, Javelle B.
HRN: 28-18-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/03/2026
01/10/2026
IV
224mg
Q6hours
Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes